Oxidative stress from reflux esophagitis to esophageal cancer: the alleviation with antioxidants (Q38816252)

6 September 2017

Oxidative stress from reflux esophagitis to esophageal cancer: the alleviation with antioxidants (English)

1 reference

6 September 2017

1 reference

1 reference

Ji Hyun Song

1

1 reference

6 September 2017

Young-Min Han

2

1 reference

6 September 2017

Won Hee Kim

3

1 reference

6 September 2017

Jong-Min Park

4

1 reference

6 September 2017

Migyeong Jeong

5

1 reference

6 September 2017

Eun Jin Go

6

1 reference

6 September 2017

Sung Pyo Hong

7

1 reference

6 September 2017

Ki Baik Hahm

8

1 reference

6 September 2017

25 April 2016

1 reference

6 September 2017

Free Radical Research

1 reference

6 September 2017

50

1 reference

6 September 2017

10

1 reference

6 September 2017

1071-1079

1 reference

Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats

6 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Risk factors for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Acid, bile, and CDX: the ABCs of making Barrett's metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

The role of Cdx2 in Barrett's metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

How does inflammation cause Barrett's metaplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Barrett's metaplasia: molecular mechanisms and nutritional influences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Translational research on Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Molecular biology of Barrett's cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Ameliorative and antioxidant effects of myrtle berry seed (Myrtus communis) extract during reflux-induced esophagitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Protective effect of Rhei Rhizoma on reflux esophagitis in rats via Nrf2-mediated inhibition of NF-κB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Effect of lycopene against gastroesophageal reflux disease in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. implications for the therapeutic use of melatonin in gastroesophageal reflux disease (GERD) and peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Molecular targets for treatment of Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Chemoprevention in Barrett's Esophagus: Current Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

The Effect of Proton Pump Inhibitors on Barrett's Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Do proton pump inhibitors protect against cancer progression in GERD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

Chemoprevention in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715762.2016.1181262

10.1080/10715762.2016.1181262

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference